Mahdavi Javad, Ahmadifar Kimiya, Ghasemikhah Reza
Students Research Committee, Arak University of Medical Sciences, Arak, Iran.
Infectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.
BMC Infect Dis. 2025 Sep 1;25(1):1085. doi: 10.1186/s12879-025-11484-3.
Giardiasis is recognized as the most prevalent enteric protozoal infection worldwide. Although gastrointestinal symptoms are the most common manifestations of giardiasis, several studies have reported cases of urticaria associated with this infection. Urticaria is a common mast cell-dependent disorder characterized by wheals, angioedema, or both. The aim of this study was to conduct the first systematic review to comprehensively synthesize the clinical, diagnostic, and therapeutic features of urticaria as a dermatologic manifestation in patients with giardiasis.
This review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement. PubMed/MEDLINE, Web of Science, Scopus, ScienceDirect, and Google Scholar were searched without language restrictions up to 2025 to identify articles reporting patients with urticaria and giardiasis.
Thirteen papers describing a total of 23 patients (14 males and 9 females, aged 4 to 56 years) were included. The locations of urticarial lesions varied, involving the head, trunk, and extremities. The duration of urticaria ranged from 8 h to 8 months. Other clinical manifestations reported in the patients included diarrhea, pruritus, abdominal distension, arthropathy, anorexia, headache, vomiting, abdominal pain, and dysphagia. Increased Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), elevated Immunoglobulin E (IgE), eosinophilia, stool examination, and Enzyme-linked immunosorbent assay (ELISA) were among the diagnostic tests utilized. Metronidazole, tinidazole, and quinacrine hydrochloride were the most commonly prescribed medications for treatment.
Our review highlights the diversity of clinical presentations and diagnostic approaches, and, for the first time, provides a consolidated resource for clinicians encountering this uncommon extraintestinal manifestation of giardiasis. In the initial evaluation of patients presenting with urticaria and a history of gastrointestinal symptoms, particularly those residing in areas with poor hygiene, potential exposure to contaminated water, or recent travel to such regions, parasitic infections, especially giardiasis, should be considered among the differential diagnoses. By addressing this under-recognized association, our study fills a significant knowledge gap regarding urticaria associated with giardiasis, ultimately facilitating earlier diagnosis, appropriate treatment, and improved patient prognosis.
贾第虫病被认为是全球最普遍的肠道原生动物感染。虽然胃肠道症状是贾第虫病最常见的表现,但多项研究报告了与这种感染相关的荨麻疹病例。荨麻疹是一种常见的肥大细胞依赖性疾病,其特征为风团、血管性水肿或两者皆有。本研究的目的是进行首次系统评价,以全面综合贾第虫病患者中作为皮肤表现的荨麻疹的临床、诊断和治疗特征。
本评价按照系统评价和Meta分析的首选报告项目(PRISMA)声明进行。检索了PubMed/MEDLINE、科学网、Scopus、ScienceDirect和谷歌学术,检索时间截至2025年,无语言限制,以识别报告荨麻疹和贾第虫病患者的文章。
纳入了13篇论文,共描述了23例患者(14例男性和9例女性,年龄4至56岁)。荨麻疹皮损部位各异,累及头、躯干和四肢。荨麻疹持续时间为8小时至8个月。患者报告的其他临床表现包括腹泻、瘙痒、腹胀、关节病、厌食、头痛、呕吐、腹痛和吞咽困难。诊断检查包括红细胞沉降率(ESR)和C反应蛋白(CRP)升高、免疫球蛋白E(IgE)升高、嗜酸性粒细胞增多、粪便检查和酶联免疫吸附测定(ELISA)。甲硝唑、替硝唑和盐酸喹吖因是最常用的治疗药物。
我们的评价突出了临床表现和诊断方法的多样性,并首次为遇到这种贾第虫病罕见肠外表现的临床医生提供了一个综合资源。在对出现荨麻疹且有胃肠道症状病史的患者进行初始评估时,特别是那些居住在卫生条件差、可能接触受污染水或近期前往此类地区的患者,鉴别诊断中应考虑寄生虫感染,尤其是贾第虫病。通过解决这种未被充分认识的关联,我们的研究填补了关于贾第虫病相关荨麻疹的重大知识空白,最终有助于早期诊断、适当治疗并改善患者预后。